Citation Impact
Citing Papers
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
WNTs in the Neonatal Mouse Uterus: Potential Regulation of Endometrial Gland Development
2010
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Mechanisms of Angiogenic Suppression in Uteri Exposed to Diethylstilbestrol Neonatally in the Mouse1
2013
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial
2016
Macrophages in immunoregulation and therapeutics
2023 Standout
Evolving synergistic combinations of targeted immunotherapies to combat cancer
2015
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Histopathological and gene expression analysis of mice exposed to diethylstilbestrol
2010
The development of immunomodulatory monoclonal antibodies as a new therapeutic modality for cancer: The Bristol-Myers Squibb experience
2014
Molecular and Cellular Basis of Regeneration and Tissue Repair
2007
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Big opportunities for small molecules in immuno-oncology
2015
Biomarkers for epithelial-mesenchymal transitions
2009 Standout
Conditional Deletion of MSX Homeobox Genes in the Uterus Inhibits Blastocyst Implantation by Altering Uterine Receptivity
2011
Immune checkpoint inhibitors: recent progress and potential biomarkers
2018 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Perinatal exposure to diethylstilbestrol alters the functional differentiation of the adult rat uterus
2013
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
2019 StandoutNobel
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Mechanisms of implantation: strategies for successful pregnancy
2012 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Nivolumab Monotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
2016
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
2017
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
2016
Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma
2016
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches
2018
Neonatal diethylstilbestrol exposure alters the metabolic profile of uterine epithelial cells
2012
Epigenetics, Evolution, Endocrine Disruption, Health, and Disease
2006
CTLA-4 and PD-1 Pathways
2015 Standout
In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy
2017
Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials
2018
Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma
2017
Works of Neysa Garner being referenced
In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates
2014
Developmental Diethylstilbestrol Exposure Alters Genetic Pathways of Uterine Cytodifferentiation
2004